+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Case ReportOpen Access

BRONJ In A Patient with Rheumatoid Arthritis: An Unnamed Association

Yusuf Ziya Şener*1 Burak Yasin Aktaş1, Levent Kılıç2, Ahmet Çağkan İnkaya3 and Umut Kalyoncu2

DOI: 10.26717/BJSTR.2017.01.000198

  • Author Information Open or Close
    • 1Department of Internal Medicine, Hacettepe University, Turkey
    • 2Department of Rheumatology, Hacettepe University, Turkey
    • 3Department of Infectious Diseases, Hacettepe University, Turkey

    Corresponding author: Yusuf Ziya Şener, Faculty of Medicine, Department of Internal Medicine, Hacettepe University, Turkey

Received: July 10, 2017;   Published: July 18, 2017

To view the Full Article   Peer-reviewed Article PDF


Bisphosphonates (BPs) are important drugs in treatment and prevention of all types of osteoporosis. BRONJ is a well known complication of BP treatment since 2002 when it was firstly described. Although most of the reported cases are patients with malignancies. Rheumatoid arthritis is a well known risk factor for BRONJ. In this report, we present a patient with BRONJ who was in our follow up due to rheumatoid arthritis.

Introduction| Case Report| Discussion| Conclusion| References|